Differences in inflammatory markers in a non-smoking and smoking Mexican population;Diferencias de marcadores de inflamación entre fumadores y no fumadores en una población mexicana

Revista de Investigacion Clinica

Volumn 61, Issue 3, 2009, Pages 205-211

  Pérez Bautista, Oliver ^a   Ramírez Venegas, Alejandra ^a   Escobar Arriaga, Elizabeth ^b   Sansores, Raúl H ^a  

^a INSTITUTO NACIONAL DE ENFERMEDADES RESPIRATORIAS   (Mexico)

^b Unidad Respiratoria del Hospital Médica Sur

Author keywords

Atherogenesis; Cancer; Cardiovascular disease; Cigarette smoking; Inflammatory markers; Systemic inflammation

Indexed keywords

ALBUMIN; C REACTIVE PROTEIN; HEMOGLOBIN; LACTATE DEHYDROGENASE; LIPID;

ADULT; ALBUMIN BLOOD LEVEL; ANTHROPOMETRY; ARTICLE; ATHEROGENESIS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; DISEASE MARKER; EXERCISE TEST; FEMALE; HEMATOCRIT; HUMAN; INFLAMMATION; LACTATE DEHYDROGENASE BLOOD LEVEL; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MEDICAL EXAMINATION; MEXICO; NEOPLASM; PROTEIN BLOOD LEVEL; RADIODIAGNOSIS; SMOKING; THROMBOCYTE; THROMBOCYTE COUNT; ULTRASOUND;

ADULT; BLOOD PROTEINS; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; CROSS-SECTIONAL STUDIES; EXERCISE TEST; FEMALE; HEMATOCRIT; HEMOGLOBINS; HUMANS; INFLAMMATION; LIPIDS; MALE; MEXICO; MIDDLE AGED; PLATELET COUNT; RISK FACTORS; SMOKING; THROMBOPHILIA; VISCERA;

EID: 70349207395     PISSN: 00348376     EISSN: 00348376     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Ezzati M, Henley SJ, Thun MJ, López AD. Role of smoking in global and regional cardiovascular mortality. Circulation 2005; 112: 489-497 (Pubitemid 41060788)
2. Ezzati M, López AD. Estimates of global mortality attributable to smoking in 2000. Lancet 2003; 362: 847-852
3. Wattanakit K, Folsom AR, Chambless LE, Nieto FJ. Risk factors for cardiovascular event recurrence in the Atherosclerosis Risk in Communities (ARIC) study. Am Heart J 2005; 149: 606-612 (Pubitemid 40501483)
4. Lu H, Ouyang W, Huang C. Inflammation, a key event in cancer development. Mol Cancer Res 2006; 4: 1-13.
5. Fowler-Brown A, Pignone M, Pletcher M, Tice JA, Sutton SF, Lohr KN. Exercise tolerance testing to screen for coronary heart disease: A systematic review for the technical support for the U.S. Preventive Services Task Force. Ann Intern Med 2004; 140: W9-W24.
6. Ridker PM. Clinical application of C-reactive protein for cardiovascular disease detection and prevention. Circulation 2003; 107: 363-369 (Pubitemid 36158034)
7. Miller MR, Hankinson J, Brusasco V, et al. Standardization of spirometry. Eur Respir J 2005; 26: 319-328
8. Aufweber E, Jorup-Ronstrom C, Edner A, Hansson LO. C-reactive protein sufficient as screening test in bacterial vs. viral infections. J Infect 1991; 23: 216-220
9. Heatherton TF, Kozlowski TL, Frecker RC, Fagerström K. The Fagerström test for Nicotine dependence: a revision of the Fagerström tolerance questionnaire. Br J Addict 1991; 86: 1119-1127
10. Erlinger TP, Muntner P, Helzlsouer KJ. WBC count and the risk of cancer mortality in a national sample of U.S. adults: Results from the Second National Health and Nutrition Examination Survey Mortality Study. Cancer Epidemiol Biomarkers Prev 2004; 13: 1052-1056 (Pubitemid 38756717)
11. Shankar A, Wang JJ, Rochtchina E, Yu MC, Kefford R, Mitchell P. Association between circulating white blood cell count and cancer mortality: a population-based cohort study. Arch Intern Med 2006; 166: 188-194
12. Shankar A, Klein BE, Klein R. Relation between white blood cell count and incident hypertension. Am J Hypertens 2004; 17: 233-239 (Pubitemid 38293328)
13. Ohshita K, Yamane K, Hanafusa M, et al. Elevated white blood cell count in subjects with impaired glucose tolerance. Diabetes Care 2004; 27: 491-496 (Pubitemid 38174077)
14. Margolis KL, Manson JE, Greenland P, et al. Leukocyte count as a predictor of cardiovascular events and mortality in postmenopausal women. Arch Intern Med 2005; 165: 500-508
15. Haim M, Boyko V, Goldbourt U, Battler A, Behar S. Predictive value of elevated white blood cell count in patients with preexisting coronary heart disease. Arch Intern Med 2004; 164: 433-439
16. Gawas M, Langer H, May AE. Platelets in inflammation and atherogenesis. J Clin Invest 2005; 115: 3378-3384
17. Vorchheimer DA, Becker R. Platelets in atherothrombosis. Mayo Clin Proc 2006; 81: 59-68.
18. Irace C, Ciamei M, Crivaro A, et al. Hematocrit is associated with carotid atherosclerosis in men but not in women. Coron Artery Dis 2003; 14: 279-284 (Pubitemid 36900656)
19. Kensey KR. The mechanistic relationships between hemorheological characteristics and cardiovascular disease. Curr Med Res Opin 2003; 19: 587-596
20. Danesh J, Wheeler JG, Hirschfield GM, et al. C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl Med 2004; 350: 1387-1397 (Pubitemid 38419992)
21. Helzlsouer KR, Erlinger TP, Platz EA. C-reactive protein levels and subsequent cancer outcomes: Results from a prospective cohort study. Eur J Cancer 2006; 42: 704-707
22. Sin DD, Man P. Why are patients with chronic obstructive pulmonary disease at increased risk of cardiovascular diseases? The potential role of systemic inflammation in chronic obstructive pulmonary disease. Circulation 2003; 107: 1514-1519
23. Shaper AG, Wannamethee SG, Whincup PH. Serum albumin and risk of stroke, coronary heart disease, and mortality: the role of cigarette smoking. J Clin Epidemiol 2004; 57: 195-202. (Pubitemid 38668614)
24. Ikonomidis I, Lekakis J, Vamvakou G, Andreotti F, Nihoyannopoulos P. Cigarette smoking is associated with increased circulating proinflammatory and procoagulant markers in patients with chronic coronary artery disease: Effects of aspirin treatment. Am Heart J 2005; 149: 832-839
25. Yasue H, Hirai N, Mizuno Y, et al. Low-grade inflammation, thrombogenicity, and atherogenic lipid profile in cigarette smokers. Circ J 2006; 70: 8-13. (Pubitemid 43021227)
26. Wannamethee SG, Lowe GDO, Shaper AG, Rumley A, Lennon L, Whincup PH. Associations between cigarette smoking, pipe/cigar smoking, and smoking cessation, and haemostatic and inflammatory markers for cardiovascular disease. Eur Heart Journal 2005; 26: 1765-1773 (Pubitemid 41219850)